Modulation of Siglec-7 Signaling Via In Situ-Created High-Affinity cis -Ligands
Senlian Hong,Chenhua Yu,Emily Rodrigues,Yujie Shi,Hongmin Chen,Peng Wang,Digantkumar G. Chapla,Tao Gao,Ruoxuan Zhuang,Kelley W. Moremen,James C. Paulson,Matthew S. Macauley,Peng Wu
DOI: https://doi.org/10.1021/acscentsci.1c00064
IF: 18.2
2021-08-13
ACS Central Science
Abstract:Sialic acid-binding immunoglobulin-like lectins, also known as Siglecs, have recently been designated as glyco-immune checkpoints. Through their interactions with sialylated glycan ligands overexpressed on tumor cells, inhibitory Siglecs on innate and adaptive immune cells modulate signaling cascades to restrain anti-tumor immune responses. However, the elucidation of the mechanisms underlying these processes is just beginning. We find that when human natural killer (NK) cells attack tumor cells, glycan remodeling occurs on the target cells at the immunological synapse. This remodeling occurs through both the transfer of sialylated glycans from NK cells to target tumor cells and the accumulation of de novo synthesized sialosides on the tumor cells. The functionalization of NK cells with a high-affinity ligand of Siglec-7 leads to multifaceted consequences in modulating a Siglec-7-regulated NK-activation. At high levels of ligand, an enzymatically added Siglec-7 ligand suppresses NK cytotoxicity through the recruitment of Siglec-7 to an immune synapse, whereas at low levels of ligand an enzymatically added Siglec-7 ligand triggers the release of Siglec-7 from the cell surface into the culture medium, preventing a Siglec-7-mediated inhibition of NK cytotoxicity. These results suggest that a glycan engineering of NK cells may provide a means to boost NK effector functions for related applications.With the formation of an immune synapse during an NK-based killing, a cancer cell upregulates its cell-surface sialylation level primarily via an accumulation of neosialylation, and its mediated immune inhibition can be blocked with a cis high-affinity ligand created chemoenzymatically, which resulted in a better tumor growth control.This article has not yet been cited by other publications.
chemistry, multidisciplinary